Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 15, 2022

SELL
$34.86 - $63.77 $7,669 - $14,029
-220 Closed
0 $0
Q3 2021

Nov 17, 2021

SELL
$47.43 - $84.23 $47,999 - $85,240
-1,012 Reduced 82.14%
220 $6,000
Q2 2021

Aug 11, 2021

BUY
$73.06 - $97.7 $90,009 - $120,366
1,232 New
1,232 $105,000

Others Institutions Holding GKOS

About GLAUKOS Corp


  • Ticker GKOS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 47,596,900
  • Market Cap $7.18B
  • Description
  • Glaukos Corporation, an ophthalmic medical technology and pharmaceutical company, focuses on the development of novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases. It offers iStent, iStent inject, iStent inject W micro-bypass stents that enhance aqueous humor outflow inserted in cataract surgery to treat mild-...
More about GKOS
Track This Portfolio

Track Wealth Quarterback LLC Portfolio

Follow Wealth Quarterback LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wealth Quarterback LLC, based on Form 13F filings with the SEC.

News

Stay updated on Wealth Quarterback LLC with notifications on news.